Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Mangalam Drugs and Organics Ltd Financial Statements & Historical Data

Updated NSE: MANGALAMBSE: 532637
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 6 October 2026, 9:05 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price31.9₹ per share
Reported P/ENot availableTimes
Book value per share65.3₹ per share
Reported ROCE14.0 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 6 October 2026, 9:05 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap49.3 Cr.
Current Price31.9
High / Low74.0/22.7
Stock P/ENot available
Book Value65.3
Dividend Yield0.00 %
ROCE14.0 %
ROE34.8 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Mangalam Drugs and Organics Ltd 49.3 Cr. 31.9 74.0/22.7 65.30.00 %14.0 %34.8 % 10.0
Biofil Chemicals & Pharmaceuticals Ltd 49.1 Cr. 30.1 46.8/25.6102 13.20.00 %2.97 %2.83 % 10.0
Vivimed Labs Ltd 50.6 Cr. 5.99 29.4/4.75 25.40.00 %65.2 %Not available 2.00
ANG Lifesciences India Ltd 51.4 Cr. 39.4 49.7/17.6 47.60.00 %1.14 %7.38 % 10.0
Bacil Pharma Ltd 39.1 Cr. 27.3 61.8/10.660.2 17.30.00 %3.93 %6.21 % 10.0
Industry Average17,530.58 Cr1,248.9854.74211.240.39%26.16%16.59%6.06

All Competitor Stocks of Mangalam Drugs and Organics Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 87.4681.5697.34102.2476.5379.9488.7172.7857.2149.5458.3867.2957.12
Expenses 90.9479.3790.3690.5468.3471.2579.9462.8861.8652.3759.9672.6556.22
Operating Profit -3.482.196.9811.708.198.698.779.90-4.65-2.83-1.58-5.360.90
OPM % -3.98%2.69%7.17%11.44%10.70%10.87%9.89%13.60%-8.13%-5.71%-2.71%-7.97%1.58%
Other Income 0.020.030.000.050.020.140.130.470.140.030.220.090.11
Interest 3.413.243.313.953.753.673.494.034.045.034.053.083.68
Depreciation 3.423.733.623.863.873.973.934.614.384.534.374.563.99
Profit before tax -10.29-4.750.053.940.591.191.481.73-12.93-12.36-9.78-12.91-6.66
Tax % -7.29%-25.05%-920.00%9.90%-355.93%-125.21%5.41%90.75%6.19%-41.42%0.00%1.16%13.36%
Net Profit -9.54-3.560.503.552.682.691.400.15-13.73-7.25-9.78-13.06-7.55
EPS in Rs -6.03-2.250.322.241.691.700.880.09-8.67-4.58-6.18-8.25-4.77

Last Updated: October 2, 2026, 9:01 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 2, 2026, 9:01 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 123221295299269228282380451372369318232232
Expenses 113200257252222218259327402347351282247241
Operating Profit 102038474710245349261736-15-9
OPM % 8%9%13%16%17%4.3%8%14%11%7%4.7%11%-6%-3.8%
Other Income 000-01015000010
Interest 1010910129109111314151616
Depreciation 44457789101115161817
Profit before tax -46243129-6640282-115-48-42
Tax % -22%-2%33%29%32%40%-32%29%29%43%-18%-39%-9%
Net Profit -36162220-8828201-97-44-38
EPS in Rs -2.314.6611.1514.0812.57-5.075.2117.6712.420.80-5.724.37-27.68-23.78
Dividend Payout % 0%0%0%0%4%0%0%0%0%0%0%0%0%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)300.00%166.67%37.50%-9.09%-140.00%200.00%250.00%-28.57%-95.00%-1000.00%177.78%-728.57%
Change in YoY Net Profit Growth (%)0.00%-133.33%-129.17%-46.59%-130.91%340.00%50.00%-278.57%-66.43%-905.00%1177.78%-906.35%

Mangalam Drugs and Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

No data available for the compounded sales growth chart.

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 2, 2026, 9:01 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 131416161616161616161616
Reserves 16477088808811513513612713387
Borrowings 78606669655270888910796105
Other Liabilities 633838545075649011710811499
Total Liabilities 170160190227211231264328358357359308
Fixed Assets 535493102103101118135142147156152
CWIP 050001669830
Investments 002000000000
Other Assets 11710095125107128140188206202201156
Total Assets 170160190227211231264328358357359308
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 14224325223128263812434
Cash from Investing Activity + -4-11-39-16-9-7-31-27-22-18-19-12
Cash from Financing Activity + -10-11-3-9-11-2333-176-226
Net Cash Flow 1-00-010-11-1-02-2
Free Cash Flow 1011391224-4-216-623-8
CFO/OP 69%68%107%66%223%129%69%70%148%71%119%-30%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow10.0011.003.009.0012.0024.00-4.00-2.0016.00-6.0023.00-8.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 887337456128525238462845
Inventory Days 170134856913217512185139200185303
Days Payable 97128373882771066365139124199
Cash Conversion Cycle 161798575111126677411210788148
Working Capital Days 292632193121102343381813
ROCE %6%16%29%31%25%2%11%27%18%6%1%8%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 50.31%50.31%50.31%50.31%50.30%50.30%50.30%50.30%50.30%35.64%35.65%35.65%
FIIs 0.10%0.10%0.26%0.21%0.11%0.11%0.47%0.53%0.11%0.13%0.32%0.11%
Public 49.59%49.59%49.42%49.47%49.58%49.58%49.23%49.16%49.57%64.22%64.03%64.24%
No. of Shareholders 17,97818,61019,17319,31219,50819,67919,69719,72819,88121,22725,14024,465

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24
FaceValue 10.0010.00
Basic EPS (Rs.) 4.25-5.73
Diluted EPS (Rs.) 4.25-5.73
Cash EPS (Rs.) 14.743.52
Book Value[Excl.RevalReserv]/Share (Rs.) 94.1285.79
Book Value[Incl.RevalReserv]/Share (Rs.) 94.1285.79
Revenue From Operations / Share (Rs.) 201.05232.87
PBDIT / Share (Rs.) 22.9511.05
PBIT / Share (Rs.) 12.461.80
PBT / Share (Rs.) 3.02-7.00
Net Profit / Share (Rs.) 4.25-5.73
NP After MI And SOA / Share (Rs.) 4.25-5.73
PBDIT Margin (%) 11.414.74
PBIT Margin (%) 6.190.77
PBT Margin (%) 1.50-3.00
Net Profit Margin (%) 2.11-2.46
NP After MI And SOA Margin (%) 2.11-2.46
Return on Networth / Equity (%) 4.51-6.68
Return on Capital Employeed (%) 11.271.67
Return On Assets (%) 1.83-2.71
Long Term Debt / Equity (X) 0.060.09
Total Debt / Equity (X) 0.540.64
Asset Turnover Ratio (%) 0.900.00
Current Ratio (X) 1.041.07
Quick Ratio (X) 0.310.31
Inventory Turnover Ratio (X) 2.430.00
Interest Coverage Ratio (X) 2.431.26
Interest Coverage Ratio (Post Tax) (X) 1.450.34
Enterprise Value (Cr.) 196.06233.41
EV / Net Operating Revenue (X) 0.610.63
EV / EBITDA (X) 5.4013.34
MarketCap / Net Operating Revenue (X) 0.360.39
Price / BV (X) 0.781.08
Price / Net Operating Revenue (X) 0.360.39
EarningsYield 0.05-0.06
Advertisements
Explore Industry-wise Company financial data